Continuing Medical Education
CME
Target Audience:
This activity has been designed to meet the educational needs of clinicians, scientists, researchers, technologists, regulatory professionals and industry experts working in the cell therapy field.
Statement of Need/Program Overview:
Because of its focus on emerging cell therapies, ISCT’s Annual Meeting will provide the most current information regarding a wide range of therapies – from tissue engineering to immunotherapy to cancer stem cells - to researchers and clinicians alike. Sessions will focus on efficacy of current therapies, challenges and successes in clinical trials and insights into practical roadblocks to large scale product development.
Educational Objectives
After completing this activity, the participant should be better able to:
- To describe the translational aspects of and issues involved with, all types of cell and tissue-based research
- To demonstrate cross-disciplinary participation from scientists, clinicians, laboratory personnel, regulatory
- professionals, and others from both academia and industry
- To identify the scientific, clinical, laboratory, and regulatory issues related to each type of cell-based research/therapy
- To translate information and experience from more mature cellular research areas such as hematopoietic stem cell transplantation to other emerging areas including non-hematopoietic areas such as mesenchymal stem cells, islet cells, ESC’s, etc
- To initiate the transfer of information and experience from senior practitioners to young scientists in the field
Faculty (For CME-Approved plenary Sessions)
- Walter Bodmer, PhD, FRCPath, FRS - University of Oxford - Weatherall Institute of Molecular Medicine, United Kingdom
- Marc Dahlke, MD, PhD - University of Regensburg, Germany
- Stefanie Dimmeler, PhD - University of Frankfurt, Germany
- Elaine Dzierzak, PhD - Erasmus MC Stem Cell Institute, The Netherlands
- Takumi Era, MD, PhD - Kumamoto University - Institute of Molecular Embryology and Genetics, Japan
- Fred Falkenburg, MD, PhD - Leiden University Medical Center, The Netherlands
- Anthony Hollander, PhD - University of Bristol, United Kingdom
- Edwin Horwitz, MD, PhD - Children’s Hospital of Philadelphia, USA
- Armand Keating, MD, FRCP(C) - Princess Margaret Hospital, Canada
- Calvin Kuo, MD, PhD - Stanford University School of Medicine, USA
- Karl-Ludwig Laugwitz, MD - University of Munich, Germany
- Douglas Losordo, MD - Feinberg Cardiovascular Research Institute, USA
- Matthias Lutolf, PhD - École Polytechnique Fédérale Lausanne, Switzerland
- Ivan Martin, PhD - University Hospital Basel, Switzerland
- Emma Morris, MA, PhD, MRCP, FRCPath - University College London Hospital, United Kingdom
- Ton Schumacher, PhD - The Netherlands Cancer Institute, The Netherlands
- Luc Sensebé, MD, PhD - Etablissement Français Du Sang EFS, France
- Marc van de Wetering, PhD - Hubrecht Institute, The Netherlands
- Catherine Verfaillie, MD - Katholieke Universiteit Leuven, Belgium
Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and The International Society for Cellular Therapy. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation:
The Postgraduate Institute for Medicine designates this live activity for a maximum of 9 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest:
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Please refer to the on site leaflet for reported financial relationships
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM planners and managers, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kimball, RN, BSN, Samantha Mattiucci, PharmD, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Method of Participation and Request for Credit:
There are no fees for participating and receiving CME credit for this activity. During the period from May 19-21, 2011, participants must read the learning objectives and faculty disclosures and study the educational activity. PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID <8000>. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA, EMA, or other regulatory bodies. PIM and The International Society for Cellular Therapy do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM and The International Society for Cellular Therapy. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Commercial Support Information:
This program is supported by an unrestricted educational grant from Amgen Inc.
CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology as meeting the criteria for 20.25 hours of CMLE credit. ASCP CMLE credit hours are acceptable to meet the continuing education requirement for the ASCP Board of Registry Certification Maintenance Program. California CMLE credits are also available for 20.25 hours.
Method of Participation and Request for Credit:
There are no fees for participating and receiving CMLE credit for this activity. CMLE credits are offered for all Plenary Sessions, Technical Sessions, Workshops, Technical Applications Track Sessions, Strategies for Commercialization Track Sessions and Oral Presentation Sessions from May 19-21 of the program.
In order to receive credit for this activity, participants must complete the evaluations for the sessions they attend. The evaluation booklet for CMLE is available at the registration desk. Alternatively, you may opt to complete the evaluation online. With the booklet, please ensure that you complete the first page of so that in the event your booklet is found, we can return it to you. At the end of the meeting, you must return the evaluation booklet to the registration desk. Online evaluation must be completed by June 17, 2011.
For the online form, click here.
CMLE certificates will be sent by email within 6-7 weeks of the program end date.
